clindamycin has been researched along with Bisphosphonate Osteonecrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HH; Chen, HM; Cheng, SJ; Chiang, CP; Kok, SH; Lee, JJ; Wang, JJ | 1 |
| Nogueira, RL; Ribeiro, NR; Santana, DM; Silva, Lde F | 1 |
| Lee, CY; Pien, FD; Suzuki, JB | 1 |
3 other study(ies) available for clindamycin and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Factors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: a 4-year cohort study.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Remodeling; Chlorhexidine; Clindamycin; Cohort Studies; Collagen Type I; Debridement; Female; Humans; Male; Middle Aged; Mouthwashes; Multivariate Analysis; Osteoporosis; Peptides; Prognosis; Retrospective Studies | 2013 |
Bisphosphonate-Related Osteonecrosis of the Jaw After Tooth Extraction.
Topics: Administration, Oral; Aged; Alendronate; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Chlorhexidine; Clindamycin; Debridement; Female; Follow-Up Studies; Humans; Mandibular Diseases; Mouthwashes; Osteoporosis, Postmenopausal; Tooth Extraction; Treatment Outcome | 2015 |
Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws.
Topics: Actinomyces; Actinomycosis; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Bisphosphonate-Associated Osteonecrosis of the Jaw; Clindamycin; Cohort Studies; Debridement; Doxycycline; Erythromycin; Female; Humans; Hyperbaric Oxygenation; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Penicillin V; Platelet-Rich Plasma; Prospective Studies; Treatment Outcome | 2011 |